Month: March 2021
-
Trial to Test Direct Crispr Blood Stem Cell Edits
A clinical trial is set to begin that tests a direct form of gene editing with Crispr to correct inherited malfunctioning genes causing sickle cell disease.
-
Coupons, Vouchers Used for Few Prescription Drugs
An analysis of customer transactions shows discounts from suppliers are used for only a small fraction of prescription drugs on the market.
-
Power Emergency
Due to a local power failure, we will not be publishing new editorial posts on Science & Enterprise for at least the rest of today.
-
Infographic – Covax Begins Vaccine Deliveries
Deliveries so far represent a small fraction of the allotments to those countries, with deliveries for other allotments not yet underway.
-
Cell-Based Fish Company Gains $8.25M in Seed Funds
The start-up enterprise Bluu Biosciences is underway creating seafood products from fish stem cells, and raising $US 8.25 million in seed funds.
-
Intensive Care Bed Designed for Preterm Babies
Clinical trial results show a hospital bed that simulates contact with a mothers’ body helps preterm babies cope with unpleasant medical procedures.
-
Microbiome Therapy Shown to Cut Covid-19 Health Needs
A clinical trial shows a treatment targeting gut microbes reduces health care use and recovery times in people with mild to moderate Covid-19 disease.
-
Clinical Trial Tests In-Tumor Breast Cancer Therapy
A clinical trial is set to begin that tests a treatment for early-stage breast cancer delivered directly into the tumor before surgery is scheduled.
-
Test Vaccine Protects Against Wide Coronavirus Range
Researchers at two Virginia universities developed an experimental vaccine that in tests with pigs protects against SARS-CoV-2 and other coronaviruses.
-
Venture Fund to Support Seed-Stage Biotechs
A venture capital company raised $50 million to invest in new businesses developing innovative products and services at the junction of biology and engineering.